GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...

Previous studies have suggested the drugs may slash the risk of illnesses like dementia and stroke, with an international ...

Weight loss injections could be key to controlling a chronic condition in thousands of Brits, new research suggests ...

(1276.HK; 600276.SH) delivered a piece of good news for investors with positive trial data for a dual-acting obesity drug ...

Researchers said the drugs should be explored as a potential treatment for obese people with the respiratory condition, who ...

Weight-loss jabs such as Mounjaro could also help minimise asthma symptoms in obese people, says a new study, as the NHS ...

Researchers say the drugs should be explored as a potential treatment for obese people with the respiratory condition.

Researchers says the drugs could be a treatment for obese people with asthma who are ‘often resistant’ to steroids ...

Weight-loss jabs could help minimise asthma symptoms in obese people, according to a study. The drugs should be explored as a ...

Roche Holding AG's H2 2025 earnings show solid growth in pharma revenues but highlight pipeline struggles and U.S. pricing pressures. Click for my RHHBY update.

Many people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to know before stopping.